Recursion Pharmaceuticals
RXRX
#5083
Rank
S$2.27 B
Marketcap
S$3.64
Share price
3.86%
Change (1 day)
-32.69%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): S-$1.16

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$1.16. In 2025 the company made an earnings per share (EPS) of S-$1.91 an increase over its 2024 EPS that were of S-$2.14.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.16-39.38%
2025S-$1.91-10.84%
2024S-$2.145.73%
2023S-$2.0214.6%
2022S-$1.7717.39%
2021S-$1.50